[Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection]
- PMID: 1377044
[Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection]
Abstract
A complex enzyme immunoassay (ELISA) has been designed for antigen-specific determination of HBsAg-containing circulating immune complexes (CIC HBsAg/IgM and CIC HBsAg/IgG) in human blood sera in parallel with registration of free HBsAg and specific antibodies to viruses of hepatitis A, B and D. It is shown that effective formation of HBsAg-containing CIC serologically is registered predominantly as a mutually incompatible marker with detection of free HBsAg (in 70-85% of the cases). CIC HBsAg/IgM and CIC HBsAg/IgG may be registered both in parallel and as mutually exclusive markers. Effective formation of HBsAg-containing CIC in the presence of anti-HBsAg occurs in case of a mild course of viral hepatitis of epidemic and sporadic type, while in severe forms of VH-free HBsAg is predominantly detected thus pointing either to ineffective formation of HBsAg-containing CIC or to their continuous registration with demonstration of the effect of delay of witching of anti-HBsM over to anti-HBsG (or CIC HBsAg/IgM to CIC HBsAg/IgG). It was also found that in case of epidemic VH in Tajik SSR (1987) serologically marked as VH both A and B convalescent phase was characterized by parallel disappearance (or lowering of the titer levels) of HBsAg-containing CIC and class M antibodies to both hepatitis A (anti-HAV M) and B (anti-HBcM, anti-HBsM) along with the containing parallel registration of relevant G-antibodies (anti-HAV G/anti-HBcG). This observation requires further studies both in terms of close association of viruses of hepatitides A and B and with regards to possible antigenic mimicry.
Similar articles
-
Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.Clin Exp Immunol. 1979 Aug;37(2):376-80. Clin Exp Immunol. 1979. PMID: 91465 Free PMC article.
-
Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.Gastroenterology. 1983 Jul;85(1):163-7. Gastroenterology. 1983. PMID: 6406288
-
[Hepatitis B and hepatitis A markers in 33 cases of acute hepatitis B surface antigen-negative, hepatitis A virus antibody-positive viral hepatitis. Importance of immune complexes].Minerva Med. 1982 Apr 28;73(18):1169-72. Minerva Med. 1982. PMID: 6281689 Italian.
-
HBsAg as the antigen component of circulating immune complexes in HIV-infected patients.Biomed Pharmacother. 2000 Apr;54(3):163-7. doi: 10.1016/S0753-3322(00)89049-6. Biomed Pharmacother. 2000. PMID: 10840593 Clinical Trial.
-
Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes.Med Lab Sci. 1990 Jul;47(3):204-9. Med Lab Sci. 1990. PMID: 2402200
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous